Atorvastatin Postpartum and Reduction of Cardiovascular Risk
Phase 4
76
about 1.2 years
20–50
Female only
1 site in OH
What this study is about
This trial is testing whether atorvastatin, a medication, reduces cardiovascular risk in postpartum women with hypertensive disorders of pregnancy. Women will be randomly assigned to either atorvastatin 10mg or a placebo after breastfeeding stops for three months.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Take Atorvastatin 10 mg
- 2.Take Placebo
Participation Burden
What's physically and logistically required of participants.
Requires travel to a study site
How treatment is administered
You may get a placebo/standard care, and you won't know which.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
atorvastatin (Statin; inhibits HMG-CoA reductase to lower cholesterol)
oral
Secondary: Estimated glomerular filtration rate, Fasting glucose, High-sensitivity C-reactive protein (Hs-CRP) level, Systolic blood pressure, Waist circumference
Reproductive Health, Cardiology / Heart